![](/us.svg)
Trademark: 97150686
Word
(KV)
Status Date
Tuesday, March 12, 2024
Filing Date
Wednesday, December 1, 2021
Published for Opposition
Tuesday, January 16, 2024
5 Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
The mark consists of the letters "KV" between two parentheses with a slash across the letters.
Color is not claimed as a feature of the mark.
Mar 12, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 16, 2024
Published For Opposition
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Dec 12, 2023
Exparte Appeal Terminated
Dec 12, 2023
Approved For Pub - Principal Register
Dec 5, 2023
Teas/Email Correspondence Entered
Dec 5, 2023
Correspondence Received In Law Office
Oct 25, 2023
Teas Request For Reconsideration Received
Oct 25, 2023
Ex Parte Appeal-Instituted
Oct 25, 2023
Jurisdiction Restored To Examining Attorney
Oct 25, 2023
Exparte Appeal Received At Ttab
Jul 21, 2023
Application Extension Granted/Receipt Provided
Jul 21, 2023
Application Extension To Response Period - Received
Apr 25, 2023
Notification Of Final Refusal Emailed
Apr 25, 2023
Final Refusal E-Mailed
Apr 25, 2023
Final Refusal Written
Mar 21, 2023
Teas/Email Correspondence Entered
Mar 20, 2023
Correspondence Received In Law Office
Mar 20, 2023
Teas Response To Office Action Received
Sep 19, 2022
Notification Of Non-Final Action E-Mailed
Sep 19, 2022
Non-Final Action E-Mailed
Sep 19, 2022
Non-Final Action Written
Sep 10, 2022
Assigned To Examiner
Dec 7, 2021
Notice Of Design Search Code E-Mailed
Dec 6, 2021
New Application Office Supplied Data Entered
Dec 4, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24